Fifth Third Bancorp Alkermes Plc. Transaction History
Fifth Third Bancorp
- $28.3 Billion
- Q2 2025
A detailed history of Fifth Third Bancorp transactions in Alkermes Plc. stock. As of the latest transaction made, Fifth Third Bancorp holds 1,116 shares of ALKS stock, worth $34,662. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,116
Previous 1,479
24.54%
Holding current value
$34,662
Previous $48,000
35.42%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding ALKS
# of Institutions
395Shares Held
176MCall Options Held
558KPut Options Held
427K-
Black Rock Inc. New York, NY29.1MShares$904 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.5MShares$575 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10MShares$312 Million0.03% of portfolio
-
State Street Corp Boston, MA8.21MShares$255 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY6.41MShares$199 Million1.86% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.1B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...